Skip to content
Screener

EyePoint, Inc. EYPT Proceeds From Stock Options Exercised And Employee Stock Purchase Plan

Proceeds From Stock Options Exercised And Employee Stock Purchase Plan at other companies

KVH Industries logo
KVH IndustriesKVHI
$552K+1,944%
Outset Medical, Inc. logo
Outset Medical, Inc.OM
$506K+24.0%
Outset Medical, Inc. logo
Outset Medical, Inc.OM
$506K+24.0%
KVH Industries logo
KVH IndustriesKVHI
$552K+1,944%
Petco Health and Wellness Company, Inc. logo
Petco Health and Wellness Company, Inc.WOOF
$1.01M+4.2%
Stewart Information Services logo
Stewart Information ServicesSTC
$2.8M-3.2%

Other financials

Income statement

See full
Revenue$507.0K-90.5%
Gross profit$9.8M-30.1%
Operating income-$97.4M-56.5%
Net income-$94.5M-59.0%
EPS (diluted)-$1.09-28.2%

Balance sheet

See full
Cash & equivalents$110.5M+55.3%
Total debt$22.4M-5.7%
Total equity$166.4M-32.4%
Total assets$228.2M-24.2%

Cash flow

See full
Operating cash flow-$62.3M+0.4%
CapEx$1.2M-1.6%
Free cash flow-$63.5M+0.4%

Valuation

See full
Market cap$1.11B+51.9%
Enterprise value$1.02B+49.6%
P/S396.6×+383×

Profitability

See full
Operating margin-11,365.2%-11,754pp
Net margin-10,994.7%-11,355pp
FCF margin-9,726.7%-10,132pp

Returns & leverage

See full
Return on equity-148.7%-13,871pp
Debt / equity0.1×0.0×
Current ratio4.5×-3.5×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept eypt:ProceedsFromStockOptionsExercisedAndEmployeeStockPurchasePlan.

The source filing: EyePoint, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335037
Line itemSix Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Proceeds from issuance of stock19,622
Payment of equity issue costs(389)(291)
Net settlement of stock units to satisfy statutory tax withholding(3,482)(1,237)
Proceeds from exercise of stock options and employee stock purchase plan1,684866
Principal payments on finance lease obligations(57)(51)
Net cash (used in) provided by financing activities17,378(713)
Net (decrease) increase in cash, cash equivalents and restricted cash8,637(28,561)
Cash, cash equivalents and restricted cash at beginning of period101,97199,854

Item 1. Unaudited Financial Statements

FAQ

What is EyePoint, Inc.'s proceeds from stock options exercised and employee stock purchase plan?
EyePoint, Inc. (EYPT) reported proceeds from stock options exercised and employee stock purchase plan of $556K in Q2 2026.
How has EyePoint, Inc.'s proceeds from stock options exercised and employee stock purchase plan changed year-over-year?
EyePoint, Inc.'s proceeds from stock options exercised and employee stock purchase plan increased by 103.7% year-over-year, from $273K to $556K.
What is the long-term trend for EyePoint, Inc.'s proceeds from stock options exercised and employee stock purchase plan?
Over 3 years (2022 to 2025), EyePoint, Inc.'s proceeds from stock options exercised and employee stock purchase plan has grown at a 78.3% compound annual growth rate (CAGR), from $395K to $2.24M.
What does proceeds from stock options exercised and employee stock purchase plan mean?
Proceeds From Stock Options Exercised And Employee Stock Purchase Plan as reported by EyePoint, Inc. Common Stock.

Ask your AI about EyePoint, Inc.'s proceeds from stock options exercised and employee stock purchase plan.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude